Investor Relations

Events

JMP Securities Life Sciences Conference
Thursday, June 20, 2019
12:30pm EDT

Intrexon Corporation and its wholly-owned Intrexon Health subsidiary Precigen, Inc., a biopharmaceutical company specializing in the development of innovative gene and cellular therapies to improve the lives of patients, presented at the JMP Securities Life Sciences Conference in New York. Helen Sabzevari, PhD, President of Precigen, highlighted Intrexon Health and Precigen in the presentation on Thursday, June 20, 2019 at 12:30 pm Eastern Time. The presentation will be archived on the Intrexon website at investors.dna.com/events and on Precigen’s website under ‘Presentations’ at www.precigen.com/media/#id-presentations for 30 days following the event.